Your browser doesn't support javascript.
loading
Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?
Shah, Nirav N; Ahn, Kwang W; Litovich, Carlos; He, Yizeng; Sauter, Craig; Fenske, Timothy S; Hamadani, Mehdi.
Afiliación
  • Shah NN; BMT and Cellular Therapy Program, Department of Medicine.
  • Ahn KW; Center for International Blood and Marrow Transplant Research, Department of Medicine, and.
  • Litovich C; Division of Biostatistics, Institute of Health and Equity, Medical College of Wisconsin, Milwaukee, WI; and.
  • He Y; Center for International Blood and Marrow Transplant Research, Department of Medicine, and.
  • Sauter C; Division of Biostatistics, Institute of Health and Equity, Medical College of Wisconsin, Milwaukee, WI; and.
  • Fenske TS; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hamadani M; BMT and Cellular Therapy Program, Department of Medicine.
Blood ; 137(10): 1416-1423, 2021 03 11.
Article en En | MEDLINE | ID: mdl-33120429
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Trasplante de Células Madre Hematopoyéticas Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Trasplante de Células Madre Hematopoyéticas Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article